Understanding MEN2 and Prophylactic Thyroidectomy

Multiple Endocrine Neoplasia Type 2 (MEN2) is a rare, inherited genetic disorder that predisposes individuals to developing various endocrine tumors, most notably medullary thyroid carcinoma (MTC). This aggressive form of thyroid cancer can arise early in life, often appearing bilaterally and multifocally in children with MEN2. Historically, before the advent of routine genetic testing for the RET proto-oncogene, many pediatric MTC cases were diagnosed at advanced, more challenging stages.

Current guidelines, such as those from the American Thyroid Association, strongly recommend prophylactic total thyroidectomy – the surgical removal of the entire thyroid gland – in children identified as carriers of specific RET mutations. This intervention is designed to prevent the development or to remove nascent MTC before it can metastasize. However, performing this surgery on younger patients presents unique challenges due to their smaller anatomical structures, particularly the parathyroid glands, which are critical for calcium regulation and are located in close proximity to the thyroid. These anatomical differences can increase the technical difficulty of the surgery and potentially elevate the risk of complications.

The Systematic Review: Scope and Methodology

The systematic review, conducted by researchers at Vanderbilt University and their affiliated pediatric otolaryngology and surgery services, aimed to answer a critical clinical question: "In children with multiple endocrine neoplasia type 2 (MEN2), what are the rates of endocrine and surgical complications after prophylactic total thyroidectomy?" To address this, the research team undertook a rigorous PRISMA-guided systematic review. They meticulously searched three major scientific databases – PubMed, Embase, and Web of Science – for original English-language studies published from 1996 onwards. The included studies encompassed retrospective and prospective research, as well as case series, specifically focusing on pediatric patients (under 18 years of age) who had undergone prophylactic thyroidectomy for MEN2.

To ensure the quality and reliability of the findings, two independent reviewers appraised the studies using the Joanna Briggs Institute tools for quality appraisal. They systematically extracted patient and cohort-level data, including demographics, MEN2 subtype, specific RET codon mutations, pathological findings of the thyroid gland, and recorded post-operative complications. Furthermore, univariate and multivariable logistic regression analyses were employed to identify potential predictors of post-operative hypocalcemia, a common endocrine complication.

Key Findings: A Balanced Risk Profile

The review synthesized data from a substantial number of patients, pooling information from 40 MEN2 cohorts across diverse international institutions. The analysis involved two tiers of data: individual-level data from 17 studies involving 53 children, and cohort-level data from an additional 23 studies encompassing 770 children.

Individual-Level Data Insights:
Among the 53 children with individual-level data, the median age at surgery was 4.58 years. The majority of these children presented with MEN2A, while a smaller proportion had MEN2B. The most frequently identified RET mutation was at codon 634. In this specific subset, 28% of the children experienced hypocalcemia, with 15% having transient hypocalcemia, 11% experiencing permanent hypocalcemia, and 2% with unspecified outcomes. Notably, the presence of malignant thyroid pathology, such as MTC or microcarcinoma, was significantly associated with transient hypocalcemia. Conversely, factors like the child’s age, sex, whether a lymph node dissection was performed, and pre-operative calcitonin levels did not emerge as significant predictors of hypocalcemia in exploratory analyses.

Cohort-Level Data and Combined Analysis:
The 23 studies contributing cohort-level data added information on an additional 770 children, bringing the total number of patients analyzed to 823. Across this larger cohort, 189 cases of hypocalcemia or hypoparathyroidism were reported. The breakdown of these outcomes was: 15% transient hypocalcemia, 6% permanent hypoparathyroidism, and 3% with unspecified outcomes. Recurrent laryngeal nerve injury, a critical surgical complication affecting voice, was reported in a low percentage of patients, less than 1% (6 cases).

Comparative Analysis and Limitations:
When compared to published series of pediatric total thyroidectomies performed for other medical reasons, the rates of transient hypocalcemia in MEN2 prophylactic thyroidectomy appeared lower. For instance, transient hypocalcemia in other pediatric thyroidectomy indications can often reach 30-40%. The rates of permanent hypoparathyroidism were found to be similar between the MEN2 cohort and those undergoing surgery for other conditions.

However, the researchers acknowledge significant limitations that temper precise risk estimations. These include considerable heterogeneity in how hypocalcemia was defined across different studies, variations in surgical techniques employed by different surgical teams, and inconsistencies in the duration and methodology of post-operative follow-up.

Implications for Clinical Practice and Future Research

The "Bottom Line" of this systematic review succinctly states that there is a moderate risk of transient hypocalcemia and low rates of major complications in children with MEN2 undergoing prophylactic thyroidectomy. This finding is crucial for clinicians and families making decisions about this life-saving surgery. The generally low morbidity observed lends support to the conclusion that the risk-benefit profile for prophylactic surgery is favorable. This implies that for children diagnosed with MEN2 and at risk of developing MTC, proceeding with thyroidectomy at an appropriate, often early, stage, is a well-justified course of action.

Dr. Ryan Belcher, MD, MPH, commented on the findings, noting that surgeons can feel "comfortable proceeding with surgery at the earliest convenience and would not need to wait to make it ‘safer.’" This perspective is particularly valuable given the inherent anxieties surrounding surgical interventions in young children. The study suggests that delaying surgery solely in the hope of improved safety due to increased age may not be necessary, provided the surgical timing aligns with established genetic risk stratification and guideline recommendations.

Despite the reassuring findings regarding surgical complications, the review highlights critical areas for future research. The sporadic reporting of long-term oncologic outcomes, such as persistent or recurrent MTC in relation to the age at surgery, RET mutation status, and calcitonin levels, underscores a significant gap in knowledge. The authors strongly advocate for the establishment of prospective registries. These registries should incorporate standardized biochemical surveillance protocols to enable better informed decision-making regarding the optimal timing of prophylactic thyroidectomy and to refine genetic counseling for families with MEN2-positive children. Such initiatives would allow for a more robust understanding of the long-term efficacy of the surgery and the dynamics of MTC development and management in this vulnerable population.

Broader Impact and Future Directions

The systematic review provides a vital evidence base for clinicians managing pediatric MEN2. By consolidating existing data, it offers a clearer picture of the risks associated with prophylactic thyroidectomy, empowering healthcare providers to engage in more informed discussions with families. The implications extend to the development of more refined surgical techniques and post-operative management strategies tailored to the unique anatomical and physiological characteristics of young patients.

The call for standardized prospective data collection is a critical takeaway. A unified approach to data gathering will allow for more precise risk stratification, better prediction of complications, and a deeper understanding of the long-term oncologic trajectory for children with MEN2. This will ultimately lead to improved patient outcomes and more personalized care plans. The research serves as a stepping stone towards a future where prophylactic thyroidectomy in MEN2 is not only a standard of care but also a procedure with comprehensively understood and meticulously managed risks, ensuring the best possible long-term health for affected children.

Citation: Lee I, et al. Outcomes of pediatric prophylactic thyroidectomy in MEN2: A systematic review. Int J Pediatr Otorhinolaryngol. 2026;207:112907. doi:10.1016/j.ijporl.2026.112907.